SCHEMBL4360121

SCHEMBL4360121

CC(C)(Cc1cccc(Br)n1)N1CCN(C(=O)O)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.46
▸ CYP1A2 P05177 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ SIRT2 Q8IXJ6 1/20 0.33
▸ KIF18A Q8NI77 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HRH3 Q9Y5N1 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ KDM1A O60341 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ GRM5 P41594 1/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ OPRM1 P35372 1/20 0.32
▸ OPRD1 P41143 1/20 0.32
▸ IRAK4 Q9NWZ3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4363955 0.82 P2RY12 (0.40) CYP1A2TSHRMEN1KMT2A
SCHEMBL29024380 0.77 — —
SCHEMBL4369708 0.77 FAAH (0.37) FAAHTP53HPGD
SCHEMBL4358419 0.76 FAAH (0.42) FAAHALDH1A1NPC1
SCHEMBL28596476 0.72 CYP1A2 (0.30) CYP1A2HRH3
SCHEMBL17721216 0.70 NPSR1 (0.39) FAAHCYP1A2SIRT2KIF18AALDH1A1
SCHEMBL1810233 0.69 KDM1A (0.36) FAAHSIRT2ALDH1A1HPGDKDM1A
SCHEMBL440473 0.69 GRIN2D (0.48) FAAHALDH1A1HPGDMEN1KMT2A
SCHEMBL1579475 0.69 GNE (0.55) FAAHALDH1A1TP53HPGDTSHR
SCHEMBL4360123 0.68 FAAH (0.38) FAAHHPGDKDM1AGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163508-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163508-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA FAAH 1/4885CYP1A2 728/4885BLM 4803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback